Live News EQUITY L impact May 28, 2026, 09:13 PM UTC

Cellectar Biosciences Files DEF 14A

Cellectar Biosciences submits regulatory filing with SEC. Filing details company's proxy statement.

SQUAWKNEWS Updated May 28, 2026, 09:14 PM UTC

Filed: 2026-05-28 AccNo: 0001104659-26-067626 Size: 2 MB